Cryoport Retains Merriman Capital as Capital Markets Advisor
SAN FRANCISCO - December 23, 2013 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (MERR), announced today that it has been retained as Capital Markets Advisor to Cryoport, Inc. ("Cryoport") (CYRX). Merriman offers small and micro capitalized companies institutional representation and issuer support, intended to help responsibly engage investors and capital markets participants.
Merriman will provide Cryoport with corporate brokerage services and advice on the effective engagement of a potentially broader institutional shareholder base, financing solutions, and strategies for organizing their capital structure. Merriman`s Capital Markets Advisory Group clients also benefit from access to unique capital solutions and the implementation of various public markets initiatives.
Cryoport provides cold chain logistics solutions to the life sciences industry, comprised of comprehensive logistics software, innovative and independently validated cryogenic packaging, and related expert logistics services. Cryoport`s logistics solutions are designed to be reliable, efficient, green and virtually eliminate degradation of the biological materials shipped. Cryoport was founded as a development company in 1999. Today, it is a solutions company with headquarters in Lake Forest, California.
"The Cryoport management and board are delighted to have the expertise of Merriman working to further our relationships and build awareness of our cold chain logistics solutions for the life sciences industry. Our solutions orientation is only a year old and is gaining market acceptance with industry leaders and we are sure that Merriman can help us accelerate the financial markets recognition of our successes and potential," said Jerrell Shelton, Cryoport`s CEO. "Our customer-centric solutions have just started to gain traction in the life sciences industry and we are now poised for future growth," Shelton continued. "We look forward to working with the talented and experienced team at Merriman Capital."
"We are excited to be working with Cryoport as their Capital Markets Advisors," commented Douglas Rogers, Managing Director and Head of the Capital Markets Advisory Group at Merriman. Doug continued, "Cryoport`s management has developed innovative cryogenic shipping solutions with powerful information technology including a cloud-based software platform that we believe could have a strong impact life sciences market space. Our Capital Markets Advisory clients benefit from a range of services including market insight, corporate brokerage services as well as strategic advice and access to capital solutions."
About Merriman Capital, Inc.
Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, as well as Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (MERR) and is the leading advisory firm for publicly traded, high-growth companies.
Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: http://www.digitalcapitalnetwork.com
Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org/ and the Securities Investor Protection Corporation (SIPC) http://www.sipc.org/.
About Cryoport, Inc.
Cryoport provides leading edge frozen shipping logistics solutions to the life sciences industry through the combination of purpose-built proprietary hardware and software technologies and skilled total turnkey management of the entire logistics process. Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration, and its Cryoportal(TM) Logistics Management Platform manages the entire shipment process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport`s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a "green" and environmentally friendly solution. Cryoport service options include recording the "chain of condition" and "chain of custody" for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.
Note to Investors
This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K-A filed on April 30, 2013 and the Form 10-Q filed on November 14, 2013. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-K-A filed on April 30, 2013 and the Form 10-Q filed on November 14, 2013, together with this press release and the financial information contained herein, are available on our website, www.merrimanco.com. Please click on "Investor Relations."
# # #
At Merriman:
Douglas Rogers
Managing Director
Merriman Capital, Inc.
(415) 248-5612
Howard Bernstein
Chief Compliance Officer
Merriman Capital, Inc.
(415) 262-1377
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Merriman Holdings Inc. via GlobeNewswire
HUG#1751899
